|Series B, 10/2013 |
Gemma Frisius Fonds
Vesalius Biocapital Partners
Capricorn Venture Partners
Trod Medical is a Medical Device Company, with headquarters in Leuven (Belgium) and Tampa Bay area (USA). The Company, incepted in 2006 by Dr. Andre Faure, developed significant expertise in developing innovative ablation technologies, particularly Radio Frequency (RF) ablation devices.
Trod Medical developed a disruptive percutaneous RF device, the EncageTM, able to ablate tissues with a degree of precision unmatched by competition. The technology represents a major breakthrough in treatments where collateral tissue damage is a significant burden to patients, like prostate cancer.
Prostate Cancer is one of the most common cancers, with around 240,000 new cases per year in the US alone, and is notably known for the inability of its commonly used treatments in avoiding significant side effects, like erectile dysfunction (impotence) and urinary incontinence.